1977
DOI: 10.1093/jnci/58.4.949
|View full text |Cite
|
Sign up to set email alerts
|

Response of Transplanted AKR Leukemia to Combination Therapy With Amphotericin Band 1,3-Bis(2-chloroethyl)-1-nitrosourea: Dose and Schedule Dependency2

Abstract: A number of different amphotericin B (AmB)-1,3-bis(2 chloroethyl)-1-nitrosourea (BCNU) treatment regimens were evaluated with our model of transplantable AKR leukemia. We found that dose levels and treatment schedules were critical in determining the number of survivors. A 4-day treatment regimen of 0.5 mg AmB/mouse on days 1, 2, 3, and 4 and 0.2 mg BCNU/mouse on day 4 was found to be the most effective and has been chosen as our standard regimen. The efficacy of the treatment regimen depended on the presence … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

1979
1979
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…AraB has been variously reported to increase (5,15) and to decrease (4,5) cell numbers in vitro. In combination with some antitunmr agents, Arab exerted synergistic effects in curing a mouse leukemia (14). The differences in growth effects noted herein seemed to depend, at least in part, upon serum content of the medium, which may also refect differences in sterol content.…”
mentioning
confidence: 70%
“…AraB has been variously reported to increase (5,15) and to decrease (4,5) cell numbers in vitro. In combination with some antitunmr agents, Arab exerted synergistic effects in curing a mouse leukemia (14). The differences in growth effects noted herein seemed to depend, at least in part, upon serum content of the medium, which may also refect differences in sterol content.…”
mentioning
confidence: 70%
“…AmB is currently used as a primary therapeutic agent for the treatment of many systemic mycoses. Several lines of evidence suggest that the drug may considerably enhance host immune response (6,14,19) and may induce macrophage activation (11). Thus, AmB administration protects mice against bacterial (20) and helminthic (17) infections and leads to increased phagocytic and antibacterial activity of peritoneal macrophages in vitro (8,11).…”
Section: Resultsmentioning
confidence: 99%
“…Amphotericin B (AmB) is a polyene antifungal antibiotic that has immunoactive properties in mice (14). Since it stimulates both humoral (6) and cell-mediated (19) immunity and also enhances host resistance to Listeria monocytogenes (20) and Schistosoma mansoni (16) infections, it can be questioned whether at least part of the antifungal activity may be attributed to its immunoactive properties (12).…”
mentioning
confidence: 99%
“…It is possible that two horizontally oriented AmB molecules and one dipalmitoyl phosphatidylcholine (DPPC) molecule in the vertical position form a stable complex that affects the thermodynamic properties of phospholipid membrane ( Minones et al, 2004 ). At the same time, in recent years, some studies have found that AmB has the potential to induce immunogenic cell death and that induction is relative to the effect of AmB on the cell membrane ( Medoff et al, 1974 ; Stein et al, 1982 ). With the gradual discovery of more functions of AmB, it is increasingly urgent to investigate the interaction mechanism between AmB and phospholipids in cell membranes.…”
Section: Introductionmentioning
confidence: 99%